Table 9.12a

Unadjusted Patient Survival, Deceased Donor Liver Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

		3 Months			1 Year			3 Years			5 Years
		N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.
Total	All	8,275	92.3%	0.3%	8,275	86.5%	0.4%	7,863	78.5%	0.5%	7,275	72.8%	0.5%
Primary Diagnosis	Non-Cholestatic Cirrhosis	5,453	92.6%	0.4%	5,453	86.3%	0.5%	5,331	77.6%	0.6%	4,731	71.0%	0.7%
	Cholestatic Liver Disease/Cirrhosis	824	93.8%	0.8%	824	90.2%	1.0%	837	85.3%	1.2%	984	80.1%	1.3%
	Acute Hepatic Necrosis	646	88.1%	1.3%	646	80.8%	1.5%	699	75.5%	1.6%	585	71.1%	1.9%
	Biliary Atresia	282	92.9%	1.5%	282	90.8%	1.7%	293	88.7%	1.8%	315	80.0%	2.3%
	Metabolic Diseases	288	93.8%	1.4%	288	91.0%	1.7%	264	83.7%	2.3%	274	81.8%	2.3%
	Malignant Neoplasms	397	93.7%	1.2%	397	86.1%	1.7%	164	63.4%	3.8%	166	60.2%	3.8%
	Other	385	89.6%	1.6%	385	84.7%	1.8%	275	75.6%	2.6%	220	69.1%	3.1%

Source: OPTN/SRTR Data as of May 3, 2004.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during 2001-2002 for 3 month and 1 year; 1999-2000 for 3 year; and 1997-1998 for 5 year survival.

Patient survival follows patients from first transplant of this type until death.

Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on liver transplants.

Multi-organ transplants are excluded.